Gerhard Dickneite

USPTO Granted Patents = 29 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 8

Forward Citations = 273(Granted Patents)

Location History:

Marburg-Cappel, DE (1986 - 1998)
Marburg, DE (1986 - 2021)

Company Filing History:

9 out of 340

Behringwerke Aktiengesellschaft

Hoechst Aktiengesellschaft

The General Hospital Corporation

patents

8. 1 out of 13

Csl Behring Lengnau Ag

patents

where one patent can have more than one assignee

Years Active: 1986-2021

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11155601 - Modified von Willebrand factor having improved half-life (2021-10-26),

2. 9987328 - Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces (2018-06-05),

3. 9624307 - Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs (2017-04-18),

4. 9452203 - Use of C1-inhibitor for the treatment of secondary edema of the central nervous system (2016-09-27),

5. 9352016 - Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces (2016-05-31),

6. 9095564 - von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes (2015-08-04),

7. 8603979 - von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes (2013-12-10),

8. 8580737 - Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates (2013-11-12),

9. 8394768 - Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates (2013-03-12),

10. 7276235 - Tissue glue with improved antiadhesive properties (2007-10-02),

11. 6790832 - Pharmaceutical preparation for the treatment of inflammatory processes (2004-09-14),

12. 6399572 - Pharmaceutical preparation for the treatment of inflammatory processes (2002-06-04),

13. 6248365 - Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura (2001-06-19),

14. 6207877 - Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding (2001-03-27),

15. 5849799 - Use of deoxyspergualin for preparing a pharmaceutical for treating (1998-12-15),

Title: Gerhard Dickneite - Pioneering Inventor from Marburg

Introduction: Gerhard Dickneite is a renowned inventor hailing from Marburg, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Gerhard Dickneite holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over three decades, Gerhard Dickneite has worked with leading research institutions and multinational corporations, playing a pivotal role in the development of cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Gerhard Dickneite has collaborated with top scientists, engineers, and industry experts, fostering a culture of innovation and knowledge sharing that has led to numerous successful projects and inventions.

Conclusion: Gerhard Dickneite's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his reputation as a visionary inventor whose work continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.